Clinical Trial Update: Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of silodosin to facilitate natural expulsion of ureteral stones has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urolithiasis

Drugs mentioned

• Rapaflo (silodosin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Ureteral Stone | Phase 4 | Status: COMPLETED